Precision Drilling
PDS
Lantheus
LNTH
eBay
EBAY
4
DexCom
DXCM
5
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
NBTX Nanobiotix
- 3.580
- -0.030-0.83%
Close Mar 31 16:00 ET
- 3.580
- 0.0000.00%
Post 20:01 ET
169.71MMarket Cap-4.48P/E (TTM)
3.580High3.470Low4.47KVolume3.490Open3.610Pre Close15.66KTurnover0.02%Turnover RatioLossP/E (Static)47.40MShares7.51052wk High-7.20P/B91.39MFloat Cap2.76052wk Low--Dividend TTM25.53MShs Float21.550Historical High--Div YieldTTM3.05%Amplitude1.750Historical Low3.506Avg Price1Lot Size
About Nanobiotix Company
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
Company Profile
SymbolNBTX
Company NameNanobiotix
Issue Price13.50
Founded2003
CEODr. Laurent Levy, PhD
MarketNASDAQ
Employees102
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address60, rue de Wattignies
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75012
Phone33-1-40-26-04-70
Websitehttp://www.nanobiotix.com
Company Executives
- Name
- Position
- Salary
- Anne-Juliette Hermant
- Chief People Officer and Member of the Executive Board
- 801.96K
- Bart Van Rhijn
- Chief Financial Officer and Member of the Executive Board
- 1.50M
- Dr. Louis Kayitalire, M.D.
- Chief Medical Officer and Member of the Executive Board
- 267.47K
- Dr. Laurent Levy, PhD
- Chairman of the Executive Board and Principal Executive Officer
- 3.40M
- Anne-Marie Graffin
- Vice Chairman of the Supervisory Board
- 42.00K
- Dr. Gary M. Phillips, M.D.
- Chairman of the Supervisory Board
- 63.00K
- Enno Spillner
- Member of the Supervisory Board
- 50.00K
- Dr. Alain Herrera, M.D.,PhD
- Member of the Supervisory Board
- 35.00K
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025